Articles
The European Heart Rhythm Association: A Myriad of Benefits and Privileges
Citation:
Arrhythmia & Electrophysiology Review 2016;5(2):82
Antiarrhythmic Drug Therapy to Avoid ICD Shocks
Citation:
Arrhythmia & Electrophysiology Review 2016;5(2):117–21
Individualising Anticoagulant Therapy in Atrial Fibrillation Patients
Citation:
Arrhythmia & Electrophysiology Review 2016;5(2):102–9
The European Heart Rhythm Association: On the Move Towards the Future of Electrophysiology
Citation:
Arrhythmia & Electrophysiology Review 2016;5(1):10-1
Consensus Document on Supraventricular Arrhythmias: A Valuable Initiative from EHRA
Citation:
Arrhythmia & Electrophysiology Review 2016;5(1):8
Atrioventricular Nodal Reentrant Tachycardia
Citation:
Arrhythmia & Electrophysiology Review 2016;5(2):130–5
Significance of Shocks in Implantable Cardioverter Defibrillator Recipients
Citation:
Arrhythmia & Electrophysiology Review 2016;5(2):110–6
Anatomical Substrates and Ablation of Reentrant Atrial and Ventricular Tachycardias in Repaired Congenital Heart Disease
Citation:
Arrhythmia & Electrophysiology Review 2016;5(2):150–60
Reducing Fluoroscopy Time and Radiation Dosage During AF Ablation
Citation:
Arrhythmia & Electrophysiology Review 2016;5(2):144–9
Controversy Surrounding ROCKET-AF: A Call for Transparency, But Should We Be Changing Practice?
Citation:
Arrhythmia & Electrophysiology Review 2016;5(1):12–3